Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
about
Inventing new medicines: The FGF21 storyBeyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesisT2 relaxation time is related to liver fibrosis severity.High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli.Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression.Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations.Fibroblast growth factor 21 is not required for the reductions in circulating insulin-like growth factor-1 or global cell proliferation rates in response to moderate calorie restriction in adult miceLoss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformationKlotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancerCharacterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsThe role of fibroblast growth factors in tumor growthFibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.Fibroblast growth factor signaling in liver carcinogenesis.The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice.Fibroblast growth factor 21 night watch: advances and uncertainties in the field.Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice.FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model.Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.A novel approach to improve the function of FGF21.Expression and function of fibroblast growth factor (FGF) 7 during liver regeneration.Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.The role of FGF21 in type 1 diabetes and its complications.FGF21 gene therapy as treatment for obesity and insulin resistance
P2860
Q26823319-0BBCFA5E-2AA0-4820-9E82-FCF36089C24BQ27026936-9A01369A-1262-4F3C-8F79-F2A7A2847511Q30383680-A341D4F3-C19B-446C-865E-C2E19D7EBBC6Q33531932-8A27FA10-5CEE-4354-84A2-50DD3D14D573Q33561352-DD2DC063-A662-478B-A936-79983CA5C9F3Q34064416-8C50FE40-413B-44E8-9AB4-4BD2E938CAB7Q34258918-E76D271A-469A-4032-8CEE-7AF07705A4D7Q34450441-9E71D8DB-DDBC-4A36-B7A3-573E06E812C6Q35835250-9871205B-2ED9-495E-8CD5-2808C8A10AB2Q35991812-CDFDB48B-00C6-49F4-8206-C29736B73B6CQ36127237-68BFA340-79F9-434B-AE4F-572A4BF526A6Q36806323-F211E45E-0DBC-4F6B-B83D-E3A58BEC48D9Q37094042-66B42FDF-5F88-4239-A145-9EAB20959161Q37512303-4781D9C9-3257-411D-8B6F-518B744F1454Q38058339-3D5DE2D8-E395-47B9-BCCB-FB0345DDD01CQ38203285-E70A3C56-F123-4EEE-9941-187F654BDCCFQ38235454-22F61B47-77F9-41AC-B97A-1A536232E6ECQ38871624-50A019E0-8221-4E13-A5B2-3AA464EB45DCQ39017842-7CF36B4C-DD7B-4192-90B3-4893B4B36F54Q41760918-74B1A83F-D60A-4B53-92BB-C54F01E6F411Q41839560-8F7F1D01-B443-4D6B-A5AF-1B355A6FC28FQ42051129-742C6198-0951-4D48-B696-75BBF66E85FBQ42552463-73CF49F5-0D3F-499C-B6C9-0D865824B424Q45324129-D67DF836-3E99-4484-821C-CD88BBE4ADD1Q46327498-ABAC0D8C-712A-4D33-AB05-9226A6673D19Q48506046-D4EEF826-BE5D-4307-8851-28402A09C73DQ54363840-025F8B5F-2CAF-42D9-899C-67E106E9749EQ55478812-269A634A-FCEF-4829-904C-8E2A2FE42999Q55490578-1B379D8A-40AD-4EF9-8947-C07C761DE998Q55513236-6DA4944E-E2E4-4312-88F8-0D714301B018Q57688659-13592F50-5A61-4479-A318-E825D9BEC9D0
P2860
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@en
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@nl
type
label
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@en
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@nl
prefLabel
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@en
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@nl
P2093
P2860
P356
P1476
Forced expression of hepatocyt ...... induced hepatocarcinogenesis.
@en
P2093
Chaofeng Yang
Chengliu Jin
Chundong Yu
Dongdong Cao
Wallace L McKeehan
Xinqiang Huang
P2860
P304
P356
10.1002/MC.20241
P577
2006-12-01T00:00:00Z